Khoom Description
Dihexa peptides tsis yog ib txwm dipeptides. Lawv tau hloov kho trimeric oligopeptides raws li angiotensin IV, tsim los ntawm pab pawg tshawb fawb ntawm Washington State University. Lawv yog cov neuroactive functional peptide raw cov ntaub ntawv nrog cov qauv tshuaj npe xws li N-hexanoyl-L-threonoyl-L- isoleucoyl-6-aminohexanamide. Lawv yog cov traceable thiab parameter -kev tshawb fawb raws li tus qauv-qib peptide raw khoom hauv kev lag luam. Dihexa peptides yog cov hmoov dawb dawb nrog cov hmoov zoo thiab sib xws. Daim ntawv dawb huv yuav luag tsis muaj ntxhiab tsw, tsuas yog muaj qhov tsis zoo ntawm micro- tsw ntawm peptides, tsis muaj tshuaj tsw qab. Cov dej solubility ntawm Dihexa peptides zoo heev, haum rau ntau yam dej-raws li cov kuab tshuaj xws li dej ntshiab, dej tsis huv ultrapure thiab buffers. Lawv tuaj yeem yaj sai sai ntawm chav tsev kub. Lawv kuj tuaj yeem hloov kho mus rau qis -concentration ethanol systems, nrog kev sib cais zoo thiab tsis muaj crystallization lossis stratification tshwm sim. Piv nrog rau feem ntau nyuaj-rau-solve neuroactive raw cov ntaub ntawv, lub siab solubility ntawm Dihexa zoo heev txo qhov nyuaj ntawm formulation npaj, thiab yog haum rau zus tau tej cov ntau npaum li cas cov ntaub ntawv xws li hmoov thiab tshuaj.

Specification
|
Khoom npe |
Dihexa |
|
CAS |
1401708-83-5 |
|
Qhov tshwm sim |
Dawb hmoov |
|
MF |
C27H44N4O5 |
|
Molecular Luj |
504.66 |
|
Purity |
99% min |
|
Cia |
Khaws rau hauv qhov chaw txias, qhuav, tsaus nti hauv ib lub thawv kaw nruj nreem lossis lub tog raj kheej |
|
Txee lub neej |
24 Lub Hlis |
COA
|
Cov khoom |
Specifications |
Cov txiaj ntsig |
|
Qhov tshwm sim |
Dawb hmoov |
Ua raws |
|
Purity |
99% min |
99.29% |
|
Ib qho Impurity (HPLC) |
1.0% max |
0.61% |
|
Amino Acid Composition |
± 10% ntawm theoretical |
Ua raws |
|
Cov ntsiab lus Peptide (N%) |
Ntau dua lossis sib npaug li 80.0% |
81.79% |
|
Cov ntsiab lus dej (Karl Fischer) |
Tsawg dua lossis sib npaug li 6.0% |
3.09% |
|
Cov ntsiab lus Acetate (HPIC) |
Tsawg dua lossis sib npaug li 15.0% |
10.84% |
|
MS (ESI) |
Zoo ib yam |
Ua raws |
|
Xam Xaj |
95.0~105.0% |
Ua raws |
|
Kev sib hloov tshwj xeeb (20 / D) |
-65.0 ~ -75.0℃(c{2}}%HAc) |
Ua raws |
|
Solubility |
H 2 O: 40 mg / mL |
Ua raws |
|
Xaus |
Ua raws li specifications |
|
Muaj nuj nqi
Dihexa Peptides muaj cov txiaj ntsig zoo heev hauv kev kho dua tshiab thiab kho cov kab mob neural synapses. Nws muaj peev xwm ua kom cov kev kho neural kho cov teeb liab txoj hauv kev hauv tib neeg lub cev, txhawb kev loj hlob thiab kev tsim kho ntawm dendritic spines ntawm neurons, kho puas thiab degenerated synaptic lug, thiab txhim kho cov teeb meem ntawm sluggish thiab qeeb neural teeb liab kis tau tus mob. Rau qhov poob ntawm neural kev ua ub no tshwm sim los ntawm ntev - lub sij hawm strain thiab aging, nws muaj peev xwm ua kom tiav kho nyob rau hauv lub cellular theem, awaken lub tseem ceeb ntawm paj hlwb, thiab ntxiv dag zog rau lub hauv paus functional mechanism ntawm lub paj hlwb.
Dihexa boasts zoo kawg li kev txawj ntse txhim kho cov teebmeem. Kev siv nws lub peev xwm muaj peev xwm nkag mus rau hauv cov ntshav - lub hlwb thaiv, cov khoom xyaw nquag hauv cov khoom siv raw tuaj yeem ncav cuag lub hauv paus paj hlwb, txhim kho cov teeb meem xws li kev nco poob, kev cuam tshuam ntawm kev xav, thiab kev xav qeeb. Tsis zoo li cov ntsiab lus luv luv -lub sij hawm soothing cov khoom xyaw, Dihexa Peptides siv cov txheej txheem tseem ceeb ntawm synaptic regeneration kom ua tiav ntev - lub sij hawm optimization ntawm lub hlwb muaj nuj nqi, stabilizing kev kawm, nco, thiab muaj peev xwm xav, thiab ua tau raws li lub sij hawm ntev - xav tau kev kho neural.
Dihexa muaj cov neuro zoo heev - tiv thaiv - mob thiab tiv thaiv - kev tiv thaiv kev laus. Nws tuaj yeem cuam tshuam qis- theem o hauv nruab nrab paj hlwb, txo qhov kev puas tsuaj rau cov paj hlwb uas tshwm sim los ntawm oxidative dawb radicals, thiab qeeb cov txheej txheem kev laus ntawm lub paj hlwb. Nws tuaj yeem txo cov teeb meem ntawm lub paj hlwb uas tshwm sim los ntawm lub sij hawm ntev - siab siab, pw tsaug zog, thiab kev qaug zog ntawm lub hlwb, txhim kho lub sub- kev noj qab haus huv xws li lub hlwb qaug zog, tsis muaj ntsuj plig, thiab qeeb cov tshuaj tiv thaiv, thiab ua tiav ob qho kev cuam tshuam ntawm neuro- tiv thaiv - laus thiab lub xeev stabilization.
Daim ntawv thov
Hauv kev tshawb fawb txog kev ua neej nyob, Diheax tam sim no tuav ib qho ntawm cov ntawv thov tseem ceeb tshaj plaws. Nws yog dav siv nyob rau hauv kev tshawb fawb ntsig txog neural regeneration mechanisms thiab kho lub hlwb raug mob, thiab yog cov tseem ceeb sim raw khoom rau cov tsev kawm ntawv lub chaw soj nstuam, biological tshawb fawb cov koom haum, thiab kws tshuaj R & D tuam txhab uas muag.
Hauv kev ua haujlwm ntawm kev noj qab haus huv cov khoom xyaw, lawv tsuas yog siv los ua cov khoom xyaw tseem ceeb ntxiv rau qib siab -kawg lub hlwb kev noj qab haus huv thiab kev txawj ntse kho cov khoom noj khoom haus ntxiv. Lawv tsim nyog rau txawv teb chaws siab -kho kev noj qab haus huv hom thiab cov khoom noj muaj txiaj ntsig zoo.
Hauv kev txhim kho biopharmaceutical, nws yog siv los ua cov khoom xyaw tseem ceeb hauv kev tsim cov tshuaj tshiab thiab kev npaj ua haujlwm rau cov xwm txheej xws li kev kho cov hlab ntsha tom qab thiab kev puas hlwb puas hlwb. Nws yog peptide-raws li raw khoom uas muaj peev xwm loj hauv biomedicine innovation sector.
Kev xa khoom



Kev them nyiaj



Pob




Cim npe nrov: Tuam Tshoj dihexa peptide manufacturers, lwm tus neeg, Hoobkas

